CJC-1295, a GHRH analogue, has been reported to produce sustained increases in growth hormone and IGF-I in healthy adults, while Ipamorelin was characterized as the first selective growth hormone secretagogue, stimulating GH release without significantly affecting ACTH or cortisol
For example, a GLP- 1/oestradiol conjugate reduced feeding and body weight in several rodent models of the metabolic syndrome [139]
doi:10.1016/S0736-0266(03)00110-4 Bock-Marquette I, Saxena A, White MD, DiMaio JM, Srivastava D
2020 In 2020, Laing et al
For the first time in a long time, we actually have the possibility for a whole new class of medications our patients [with addiction] might benefit from, shared Dr